These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7470192)

  • 1. An abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-II.
    Stocks J; Holdsworth G; Dodson P; Galton DJ
    Atherosclerosis; 1981; 38(1-2):1-9. PubMed ID: 7470192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III.
    Holdsworth G; Stocks J; Dodson P; Galton DJ
    J Clin Invest; 1982 Apr; 69(4):932-9. PubMed ID: 7076853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II.
    Reckless JP; Stocks J; Holdsworth G; Galton DJ; Suggett AJ; Walton KW
    Clin Sci (Lond); 1982 Jan; 62(1):93-100. PubMed ID: 7056035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.
    Stalenhoef AF; Malloy MJ; Kane JP; Havel RJ
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1839-43. PubMed ID: 6584917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles.
    Lambert DA; Catapano AL; Smith LC; Sparrow JT; Gotto AM
    Atherosclerosis; 1996 Dec; 127(2):205-12. PubMed ID: 9125310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency.
    Catapano AL; Mills GL; Roma P; La Rosa M; Capurso A
    Clin Chim Acta; 1983 Jun; 130(3):317-27. PubMed ID: 6872264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2.
    Stocks J; Holdsworth G; Galton D
    Lancet; 1979 Sep; 2(8144):667-71. PubMed ID: 90760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
    Forte TM; Nichols AV; Krauss RM; Norum RA
    J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase.
    Jackson RL; Tajima S; Yamamura T; Yokoyama S; Yamamoto A
    Biochim Biophys Acta; 1986 Feb; 875(2):211-9. PubMed ID: 3942763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human chylomicrons.
    Haberbosch W; Poli A; Augustin J
    Biochim Biophys Acta; 1982 Nov; 713(2):398-409. PubMed ID: 7150620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
    Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.